Indicated for: cancer
Route of administration: infusion
Substance: cisplatin (antineoplastic agent)
ATC: L01XA01 (Antineoplastic and immunomodulating agents | Other antineoplastic agents | Platinum compounds)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
This medicine may affect the kidneys.
This medicine may affect the nerves or nervous system.
This medicine may affect hearing or balance.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Cisplatin is a chemotherapy medication used for the treatment of various types of cancer, including testicular, ovarian, bladder, and lung cancer. It works by binding to the DNA of tumor cells, inhibiting their replication and inducing cell death.
The medication is administered intravenously, as directed by a doctor, usually in a hospital or specialized clinic. It is important for patients to be monitored to prevent severe side effects.
Patients should be aware of potential side effects, such as nausea, vomiting, kidney dysfunction, or ototoxicity. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, vomiting, and fatigue. In rare cases, severe reactions such as kidney failure or hearing loss may occur. Patients should be informed of these risks before starting treatment.